Finally, we validated that LINC00839 acts as a ceRNA to upregulate NLRP3 mRNA via sequestering miR-223, and the LINC00839/miR-233 axis was the regulatory target of sevoflurane in ALI (Fig. 7). The gene discussed is NLRP3; the disease is acute respiratory distress syndrome.